- ORCID iD
-
0000-0003-2506-680X
Show
Sort by
-
- Journal Article
- A1
- open access
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
-
The self-amplifying RNA platform for vaccination and in vivo controllable production of therapeutic proteins
(2022) -
In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation
-
Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs
-
- Journal Article
- A1
- open access
Immunogenicity and protection efficacy of a naked self-replicating mRNA-based Zika virus vaccine
-
- Journal Article
- A1
- open access
Improving the repeatability and efficacy of intradermal electroporated self-replicating mRNA
-
- Journal Article
- A1
- open access
Mononuclear but not polymorphonuclear phagocyte depletion increases circulation times and improves mammary tumor-homing efficiency of donor bone marrow-derived monocytes
-
- Journal Article
- A1
- open access
Expression kinetics and innate immune response after electroporation and LNP-mediated delivery of a self-amplifying mRNA in the skin
-
- Journal Article
- A1
- open access
Bovine embryo-secreted microRNA-30c is a potential non-invasive biomarker for hampered preimplantation developmental competence
-
mRNA therapeutics deliver a hopeful message